Skip to main content
Premium Trial:

Request an Annual Quote

Genedata Extends Support of Affy Platform to Exon Arrays

NEW YORK (GenomeWeb News) - Genedata said today that its Expressionist biomarker-discovery software has gained Affymetrix GeneChip-compatible status for exon expression applications.
 
A company spokesman said that Expressionist was previously compatible only with Affy’s expression arrays. He said that expanding support to exon expression analysis required file format changes as well as additional “data hierarchy” capabilities because each gene may have multiple exons that each have multiple probes.
 
In addition, he said that data volumes for the exon arrays are larger than expression arrays, because they contain 1.4 million probe sets instead of 500,000.
 
Expressionist includes a Refiner Array module for quality assessment and processing of GeneChip exon data, Genedata said.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.